Avi Katz, the chairman of QT Imaging Holdings, Inc. (NASDAQ: QTIH), purchased 24,107 shares of the company’s common stock at a price of $6.43 per share on January 22, 2026, a transaction that totaled $155,008. Following the acquisition, Katz’s direct ownership in the company stands at 413,452 shares.
Alongside the common stock purchase, Katz also acquired 48,214 private warrants. Those warrants are exercisable for common stock at an exercise price of $6.43 and carry an expiration date of July 22, 2036.
QT Imaging has reported several other developments in recent filings. The company said it met its 2025 revenue objective of more than $18 million after shipping 40 medical scanners during the year. Management disclosed that this revenue level represents a 285% increase compared with results in 2024.
On the company’s liquidity position, QT Imaging indicated it expects to finish 2025 with at least $10 million in cash. That projected year-end balance contrasts with $1.2 million in cash at the close of 2024, according to the filing.
QT Imaging also announced an addition to its leadership team with the appointment of Satrajit Misra as Chief Commercial Officer, a newly created executive role. The filing notes Misra’s prior experience at Canon Medical Systems USA, Philips, and Siemens Healthcare.
Finally, QT Imaging implemented a 3:1 reverse stock split that is now market effective. The reverse split applies to all issued and outstanding shares of the company’s common stock, as stated in the SEC filing.
These actions - the chairman’s open-market purchases and warrants acquisition, the company’s reported revenue milestone and shipment tally, the projected increase in cash, the creation of a commercial leadership position, and the market-effective reverse split - are documented in the company’s recent disclosures and filings.